Literature DB >> 11922772

Estrogen-dependent regulation of the expression of hepatic Cyp2b and 3a isoforms: assessment using aromatase-deficient mice.

Hideyuki Yamada1, Noriko Gohyama, Shin-ichiro Honda, Takayuki Hara, Nobuhiro Harada, Kazuta Oguri.   

Abstract

The role of estrogen in the expression and induction of hepatic Cyp2b and Cyp3a isoforms was studied using mice [Ar (-/-) mice] lacking aromatase, a key enzyme for estrogen biosynthesis. The expression of P450s was determined by reverse transcription-polymerase chain reaction, immunoblotting, and measuring testosterone 6beta- and 16alpha-hydroxylase activity as markers. Basic expression of Cyp3a11 mRNA and protein was seen in both sexes of Ar (+/+) mice. Disruption of the aromatase gene caused an increase in the expression of Cyp3a11 protein, although the mRNA level remained unchanged. Female-specific Cyp3a41 disappeared in Ar (-/-) mice, and this could not be reversed by administration of exogenous beta-estradiol to adult knockout mice. The constitutive expression of female-specific Cyp2b9 also disappeared on disrupting the aromatase gene. However, in clear contrast to Cyp3a41, some individual Ar (-/-) mice exhibited expression of this form following treatment with exogenous beta-estradiol. Disruption of the aromatase gene had no effect on PB-mediated induction of Cyp2b10 or on the noninducible nature of Cyp2b9, Cyp3a11, and Cyp3a41. These results suggest that (1) Cyp3a11 is suppressed by estrogen; (2) the expression of female-specific Cyp3a41 is programmed by neonatal and/or infantile exposure to estrogen; (3) maintenance of the expression of female-specific Cyp2b9 requires estrogen in adults; and (4) endogenous estrogen plays little, if any, role in the mechanism by which PB induces Cyp2b10. (c)2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11922772     DOI: 10.1006/taap.2002.9366

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  7 in total

1.  Pregnane X receptor-mediated induction of Cyp3a by black cohosh.

Authors:  Xiaoyan Pang; Jie Cheng; Kristopher W Krausz; De-an Guo; Frank J Gonzalez
Journal:  Xenobiotica       Date:  2010-10-27       Impact factor: 1.908

2.  Gender-specific induction of cytochrome P450s in nonylphenol-treated FVB/NJ mice.

Authors:  Juan P Hernandez; Laura M Chapman; Xiomara C Kretschmer; William S Baldwin
Journal:  Toxicol Appl Pharmacol       Date:  2006-05-25       Impact factor: 4.219

3.  Hepatic bile acid metabolism and expression of cytochrome P450 and related enzymes are altered in Bsep (-/-) mice.

Authors:  Eugene Hrycay; Dana Forrest; Lin Liu; Renxue Wang; Jenny Tai; Anand Deo; Victor Ling; Stelvio Bandiera
Journal:  Mol Cell Biochem       Date:  2014-01-08       Impact factor: 3.396

4.  Sexually dimorphic regulation and induction of P450s by the constitutive androstane receptor (CAR).

Authors:  J P Hernandez; L C Mota; W Huang; D D Moore; W S Baldwin
Journal:  Toxicology       Date:  2008-11-11       Impact factor: 4.221

5.  Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver.

Authors:  G Bryzgalova; H Gao; B Ahren; J R Zierath; D Galuska; T L Steiler; K Dahlman-Wright; S Nilsson; J-A Gustafsson; S Efendic; A Khan
Journal:  Diabetologia       Date:  2006-02-04       Impact factor: 10.122

6.  Compensatory changes in CYP expression in three different toxicology mouse models: CAR-null, Cyp3a-null, and Cyp2b9/10/13-null mice.

Authors:  Ramiya Kumar; Linda C Mota; Elizabeth J Litoff; John P Rooney; W Tyler Boswell; Elliott Courter; Charles M Henderson; Juan P Hernandez; J Christopher Corton; David D Moore; William S Baldwin
Journal:  PLoS One       Date:  2017-03-28       Impact factor: 3.240

7.  Effect of pregnancy on cytochrome P450 3a and P-glycoprotein expression and activity in the mouse: mechanisms, tissue specificity, and time course.

Authors:  Huixia Zhang; Xiaohui Wu; Honggang Wang; Andrei M Mikheev; Qingcheng Mao; Jashvant D Unadkat
Journal:  Mol Pharmacol       Date:  2008-05-28       Impact factor: 4.054

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.